2025
COVID-19 vaccine-associated reactive axillary lymph nodes on FDG PET/CT: a systematic review and meta-analysis.
Adin M, Nguyen D, Shin C, Pucar D. COVID-19 vaccine-associated reactive axillary lymph nodes on FDG PET/CT: a systematic review and meta-analysis. Nuclear Medicine Communications 2025 PMID: 40900040, DOI: 10.1097/mnm.0000000000002041.Peer-Reviewed Original ResearchNon-mRNA vaccinesAxillary lymph nodesFluorodeoxyglucose PET/CTLymph nodesMeta-analysisMaximum standardized uptake valueVaccine typesFluorodeoxyglucose PET/CT imagesStandardized uptake valueCOVID-19 vaccineModerna mRNA vaccineSystematic reviewPET/Computed TomographyPET/CT imagingMalignant lymphadenopathyVaccine-related factorsUptake valueMRNA vaccinesFluorodeoxyglucosePrimary outcomeReactive nodesPET/CTSecondary outcomesInterpretation criteriaPostvaccinal immunity
2024
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients
Matthews D, Kinney J, Ritter A, Andrews R, Strom E, Lukic A, Koenig L, Revta C, Fillit H, Zhong K, Tousi B, Leverenz J, Feldman H, Cummings J. Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients. Alzheimer's & Dementia: Translational Research & Clinical Interventions 2024, 10: e12490. PMID: 38988416, PMCID: PMC11233274, DOI: 10.1002/trc2.12490.Peer-Reviewed Original ResearchFluorodeoxyglucose positron emission tomographyGlial fibrillary acidic proteinPositron emission tomographyMagnetic resonance imagingPlasma biomarkersVolumetric magnetic resonance imagingMild to moderate ADFDG positron emission tomographyPhase 2 clinical trialNeurofilament light chainGlial fibrillary acidic protein concentrationFibrillary acidic proteinInflammation-related proteinsTemporal cortexLeft inferior temporal cortexModerate ADCognitive endpointsFluorodeoxyglucosePET uptakeInflammation biomarkersBaseline MMSEMild-to-moderate Alzheimer's disease patientsImaging biomarkersBiomarker heterogeneityEmission tomography
2008
MR Imaging in Diagnosis and Staging of Pulmonary Carcinoma
Godelman A, Haramati L. MR Imaging in Diagnosis and Staging of Pulmonary Carcinoma. Magnetic Resonance Imaging Clinics Of North America 2008, 16: 309-317. PMID: 18474334, DOI: 10.1016/j.mric.2008.02.013.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
1995
Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocarclial viability
Soufer R, Dey H, Ng C, Zaret B. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocarclial viability. The American Journal Of Cardiology 1995, 75: 1214-1219. PMID: 7778542, DOI: 10.1016/s0002-9149(99)80765-6.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCoronary DiseaseDeoxyglucoseFluorine RadioisotopesFluorodeoxyglucose F18HumansMaleMiddle AgedMyocardial ContractionRadionuclide VentriculographyStroke VolumeTechnetium Tc 99m SestamibiTomography, Emission-ComputedTomography, Emission-Computed, Single-PhotonVentricular Function, LeftConceptsPositron emission tomographySestamibi single-photon emissionSingle photon emissionCoronary artery diseaseMyocardial viabilityInferior wallArtery diseaseEmission tomographyFDG positron emission tomographySubset of patientsRegional ejection fractionDiscordant segmentsNonviable segmentsEjection fractionMethoxyisobutyl isonitrileRadionuclide ventriculographySestamibi protocolBlood flowMyocardial segmentsPatientsViable segmentsFluorodeoxyglucoseMIBITomographyDisease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply